Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joost B Beltman

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Scientific Reports|March 15, 2022
Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patientsImke B Bruns, Joost B Beltman
Frontiers in Oncology|November 17, 2016
Combination Approaches with Immune-Checkpoint Blockade in Cancer TherapyMaarten Swart, Inge Verbrugge, Joost B Beltman
Evolution; International Journal of Organic Evolution|April 3, 2004
Learning and colonization of new niches: a first step toward speciationJoost B Beltman, Patsy Haccou, Carel ten Cate
Cancer Research|May 2, 2019
Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression <i>In Vivo</i>Richard J Beck, Maarten Slagter, Joost B Beltman
Cancers|June 2, 2021
Mathematical Modelling Based on In Vivo Imaging Suggests CD137-Stimulated Cytotoxic T Lymphocytes Exert Superior Tumour Control Due to an Enhanced Antimitotic Effect on Tumour CellsRichard J Beck, Bettina Weigelin, Joost B Beltman
Plos Computational Biology|February 13, 2018
Heritable tumor cell division rate heterogeneity induces clonal dominanceMargriet M Palm, Marjet Elemans, Joost B Beltman
Plos Computational Biology|July 14, 2020
Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging dataRichard J Beck, Dario I Bijker, Joost B Beltman
Frontiers in Immunology|August 28, 2023
Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 statusCarlijn M Lems, Gerhard A Burger, Joost B Beltman
Immunology Letters|August 18, 2015
What do mathematical models tell us about killing rates during HIV-1 infection?Saikrishna Gadhamsetty, Joost B Beltman, Rob J de Boer
Pharmaceutics|September 28, 2023
Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and HumansRaju Prasad Sharma, Elsje J Burgers, Joost B Beltman
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|March 15, 2022
Quantifying the contribution of transcription factor activity, mutations and microRNAs to CD274 expression in cancer patientsImke B Bruns, Joost B Beltman
Frontiers in Oncology|November 17, 2016
Combination Approaches with Immune-Checkpoint Blockade in Cancer TherapyMaarten Swart, Inge Verbrugge, Joost B Beltman
Evolution; International Journal of Organic Evolution|April 3, 2004
Learning and colonization of new niches: a first step toward speciationJoost B Beltman, Patsy Haccou, Carel ten Cate
Cancer Research|May 2, 2019
Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression <i>In Vivo</i>Richard J Beck, Maarten Slagter, Joost B Beltman
Cancers|June 2, 2021
Mathematical Modelling Based on In Vivo Imaging Suggests CD137-Stimulated Cytotoxic T Lymphocytes Exert Superior Tumour Control Due to an Enhanced Antimitotic Effect on Tumour CellsRichard J Beck, Bettina Weigelin, Joost B Beltman
Plos Computational Biology|February 13, 2018
Heritable tumor cell division rate heterogeneity induces clonal dominanceMargriet M Palm, Marjet Elemans, Joost B Beltman
Plos Computational Biology|July 14, 2020
Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging dataRichard J Beck, Dario I Bijker, Joost B Beltman
Frontiers in Immunology|August 28, 2023
Tumor-mediated immunosuppression and cytokine spreading affects the relation between EMT and PD-L1 statusCarlijn M Lems, Gerhard A Burger, Joost B Beltman
Immunology Letters|August 18, 2015
What do mathematical models tell us about killing rates during HIV-1 infection?Saikrishna Gadhamsetty, Joost B Beltman, Rob J de Boer
Pharmaceutics|September 28, 2023
Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and HumansRaju Prasad Sharma, Elsje J Burgers, Joost B Beltman
Pageof 6